Guerbet is a limited liability company incorporated under the laws of France with securities listed on Euronext Paris, France. Consequently, our corporate governance framework reflects the mandatory provisions of French corporate law, the securities laws and regulations applying to Guerbet as a corporation listed in France States. In addition, the Company’s corporate governance principles refer to the AFEP-MEDEF Code.

On May 21, 2010, Guerbet adopted the French form of a joint stock company governed by a Board of Directors (Société Anonyme à Conseil d'administration). This legal structure upholds a clear separation between management functions assumed by the Executive Committee and the functions of oversight assured by the Board of Directors, which represents the shareholders..

 

Board of Directors

Antoine Fady

Chairman of the Board, Independent Director
 

Vincent Dagommer

Director

Marie de La Simone

Director representing the employees

Eric Drapé

Independent Director

Eric Guerbet

Director

Olivier Guerbet

Director

Céline Lamort

Director

Michèle Lesieur

Independent Director

Emmanuelle Louvet

Director

Executive Committee

Karim Boussebaa

Chief Executive Officer 
 

Christine Allard

SVP Public Affairs and Corporate Communications

Charlotte Bamière

General Counsel & SVP Compliance

Philippe Bourrinet

SVP Development, Medical & Regulatory Affairs and Group Responsible Pharmacist

Valérie Brissart

SVP Marketing - Diagnostic Imaging

François Convenant

SVP Interventional Radiology

Jérôme Estampes

Group Chief Financial Officer & SVP Business Development & licensing
 

Eric Kummer

SVP Technical Operations

François Nicolas

SVP Research, Development, Innovation and AI

Eva Ohlsson

SVP Human Resources